Milia en plaque

From WikiMD's WELLNESSPEDIA


Milia en plaque
Synonyms
Pronounce N/A
Specialty Dermatology
Symptoms Milia, erythematous plaque
Complications N/A
Onset
Duration
Types N/A
Causes Unknown
Risks
Diagnosis Clinical diagnosis, skin biopsy
Differential diagnosis Lichen planus, discoid lupus erythematosus, sarcoidosis
Prevention N/A
Treatment Topical retinoids, corticosteroids, laser therapy
Medication
Prognosis Generally good
Frequency Rare
Deaths N/A


Milia en plaque is a rare cutaneous condition characterized by multiple milia that are set on an erythematous base, or plaque. This condition was first described in 1978 and is considered a subtype of primary milia.

Etiology[edit]

The exact cause of milia en plaque is unknown. However, it is believed to be associated with damage to the sweat glands or hair follicles. Some studies suggest that it may be related to genetic factors, as it has been observed in families with a history of the condition.

Clinical Features[edit]

Milia en plaque typically presents as a plaque of numerous small, white, dome-shaped papules. These papules are milia, which are small cysts filled with keratin. The plaque is usually located on the ears, eyelids, cheeks, or jaw area. The condition is usually asymptomatic, but some patients may experience mild itching or discomfort.

Diagnosis[edit]

Diagnosis of milia en plaque is primarily based on clinical examination. The distinctive appearance of the plaque and the presence of milia make it relatively easy to identify. In some cases, a skin biopsy may be performed to confirm the diagnosis and rule out other conditions.

Treatment[edit]

Treatment for milia en plaque is not always necessary, as the condition is benign and does not cause serious health problems. However, treatment may be desired for cosmetic reasons or to alleviate any discomfort. Treatment options include topical retinoids, dermabrasion, and laser therapy.

Prognosis[edit]

The prognosis for milia en plaque is generally good. The condition does not cause serious health problems and does not affect a person's lifespan. However, it can cause cosmetic concerns and may recur after treatment.

See Also[edit]


This rare disease-related article is a stub. You can help WikiMD by expanding it.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.